299165-27-8 Usage
Uses
Used in Pharmaceutical Industry:
AMINO(4-TERT-BUTYLPHENYL)ACETIC ACID is used as an anti-inflammatory and analgesic agent for the treatment of conditions characterized by pain and inflammation, such as arthritis and menstrual cramps. It is effective due to its ability to inhibit prostaglandin production, thereby reducing the associated symptoms.
Used in Pain Management:
Flurbiprofen is utilized as a pain reliever to manage mild to moderate pain resulting from various conditions, by reducing inflammation and the associated discomfort.
Used in Inflammation Reduction:
In conditions where inflammation is a key factor, AMINO(4-TERT-BUTYLPHENYL)ACETIC ACID is employed to decrease inflammation, providing relief from the swelling and discomfort that can accompany such conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 299165-27-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,9,9,1,6 and 5 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 299165-27:
(8*2)+(7*9)+(6*9)+(5*1)+(4*6)+(3*5)+(2*2)+(1*7)=188
188 % 10 = 8
So 299165-27-8 is a valid CAS Registry Number.
299165-27-8Relevant academic research and scientific papers
Synthesis of Unprotected 2-Arylglycines by Transamination of Arylglyoxylic Acids with 2-(2-Chlorophenyl)glycine
Inada, Haruki,Shibuya, Masatoshi,Yamamoto, Yoshihiko
, p. 11047 - 11059 (2020/10/12)
The transamination of α-keto acids with 2-phenylglycine is an effective methodology for directly synthesizing unprotected α-amino acids. However, the synthesis of 2-arylglycines by transamination is problematic because the corresponding products, 2-arylglycines, transaminate the starting arylglyoxylic acids. Herein, we demonstrate the use of commercially available l-2-(2-chlorophenyl)glycine as the nitrogen source in the transamination of arylglyoxylic acids, producing the corresponding 2-arylglycines without interference from the undesired self-transamination process.
